Sweden · Delayed Price · Currency is SEK BioArctic AB Statistics
Total Valuation
BioArctic AB has a market cap or net worth of SEK 17.02 billion. The enterprise value is 16.28 billion.
| Market Cap | 17.02B |
| Enterprise Value | 16.28B |
Important Dates
The next estimated earnings date is Thursday, August 28, 2025.
| Earnings Date | Aug 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BioArctic AB has 88.53 million shares outstanding. The number of shares has increased by 0.36% in one year.
| Current Share Class | 74.13M |
| Shares Outstanding | 88.53M |
| Shares Change (YoY) | +0.36% |
| Shares Change (QoQ) | +0.24% |
| Owned by Insiders (%) | 33.55% |
| Owned by Institutions (%) | 48.09% |
| Float | 53.07M |
Valuation Ratios
The trailing PE ratio is 18.88 and the forward PE ratio is 19.75.
| PE Ratio | 18.88 |
| Forward PE | 19.75 |
| PS Ratio | 11.21 |
| PB Ratio | 8.80 |
| P/TBV Ratio | 8.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.08, with an EV/FCF ratio of -75.09.
| EV / Earnings | 18.05 |
| EV / Sales | 10.73 |
| EV / EBITDA | 17.08 |
| EV / EBIT | 17.70 |
| EV / FCF | -75.09 |
Financial Position
The company has a current ratio of 13.39, with a Debt / Equity ratio of 0.03.
| Current Ratio | 13.39 |
| Quick Ratio | 5.21 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.05 |
| Debt / FCF | -0.24 |
| Interest Coverage | 65.14 |
Financial Efficiency
Return on equity (ROE) is 61.64% and return on invested capital (ROIC) is 38.56%.
| Return on Equity (ROE) | 61.64% |
| Return on Assets (ROA) | 35.28% |
| Return on Invested Capital (ROIC) | 38.56% |
| Return on Capital Employed (ROCE) | 46.65% |
| Revenue Per Employee | 13.08M |
| Profits Per Employee | 7.78M |
| Employee Count | 107 |
| Asset Turnover | 0.93 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BioArctic AB has paid 31.99 million in taxes.
| Income Tax | 31.99M |
| Effective Tax Rate | 3.43% |
Stock Price Statistics
The stock price has decreased by -15.93% in the last 52 weeks. The beta is -0.75, so BioArctic AB's price volatility has been lower than the market average.
| Beta (5Y) | -0.75 |
| 52-Week Price Change | -15.93% |
| 50-Day Moving Average | 185.96 |
| 200-Day Moving Average | 188.64 |
| Relative Strength Index (RSI) | 57.93 |
| Average Volume (20 Days) | 106,962 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioArctic AB had revenue of SEK 1.52 billion and earned 901.96 million in profits. Earnings per share was 10.18.
| Revenue | 1.52B |
| Gross Profit | 1.48B |
| Operating Income | 919.83M |
| Pretax Income | 933.95M |
| Net Income | 901.96M |
| EBITDA | 939.30M |
| EBIT | 919.83M |
| Earnings Per Share (EPS) | 10.18 |
Balance Sheet
The company has 788.57 million in cash and 50.99 million in debt, giving a net cash position of 737.57 million or 8.33 per share.
| Cash & Cash Equivalents | 788.57M |
| Total Debt | 50.99M |
| Net Cash | 737.57M |
| Net Cash Per Share | 8.33 |
| Equity (Book Value) | 1.93B |
| Book Value Per Share | 21.85 |
| Working Capital | 1.88B |
Cash Flow
In the last 12 months, operating cash flow was -190.14 million and capital expenditures -26.64 million, giving a free cash flow of -216.77 million.
| Operating Cash Flow | -190.14M |
| Capital Expenditures | -26.64M |
| Free Cash Flow | -216.77M |
| FCF Per Share | -2.45 |
Margins
Gross margin is 97.61%, with operating and profit margins of 60.62% and 59.44%.
| Gross Margin | 97.61% |
| Operating Margin | 60.62% |
| Pretax Margin | 61.55% |
| Profit Margin | 59.44% |
| EBITDA Margin | 61.91% |
| EBIT Margin | 60.62% |
| FCF Margin | n/a |
Dividends & Yields
BioArctic AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.36% |
| Shareholder Yield | n/a |
| Earnings Yield | 5.30% |
| FCF Yield | -1.27% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |